AerovectRx Management Team
2 Team Members
AerovectRx has 2 executives. AerovectRx's former Chief Executive Officer is David Johnston.
You May Also Like
Depotech is developing methods for drug delivery
PharmaJet develops, manufactures and markets vaccine and drug delivery products based on its proprietary needle free jet injection technology. PharmaJet's needle‐free injection technology delivers drugs and vaccines to intramuscular, subcutaneous and intradermal tissue depths. PharmaJet injectors use pressure to create a fine stream of liquid that penetrates the skin, delivering doses to the desired depth, while eliminating risks of needle‐stick injuries and the cost burden of "sharps" waste management. Further benefits of PharmaJet injectors include the potential for dose‐sparing of vaccines, reducing the overall cost of vaccine delivery.
Medlogics is an early stage medical device company developing a broad platform technology for drug delivery. The initial focus is product development of polymer-free stent drug delivery.
Pantec Biosolutions is a provider of transdermal drug delivery solutions.
Cytogel, Inc., is working on the development of promising drug candidates and drug delivery technologies
Replenish Inc is a Pasadena, Calif.-based developer of a drug delivery platform.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.